1 PRIMECAP Management AstraZeneca PLC Trades
PRIMECAP Management acquired 18.2M AstraZeneca PLC shares worth $3.46B. That's 2.13% of their equity portfolio (9th largest holding). The investor owns 1.17% of the outstanding AstraZeneca PLC stock. The investor's estimated purchase price is $3.48B, resulting in a loss of 0.5%.
News about AstraZeneca PLC and PRIMECAP Management
Princeton Global Asset Management LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Princeton Global Asset Management LLC grew its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 77.5% during the third quarter, according ...
AIM ImmunoTech Inc.: AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca''s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and what th...
Moran Wealth Management LLC Sells 453 Shares of AstraZeneca PLC (NASDAQ:AZN)
Moran Wealth Management LLC decreased its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.4% in the 2nd quarter, Holdings Channel repor...
Why Legend Mining, Medibank, Starpharma, and Weebit Nano shares are sinking
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) looks set to end its losing streak. At the time of writing, the benchmark index is up 0.5% to 7,116 poi...